Development and clinical consequences of white matter lesions in Fabry disease: a systematic review
- PMID: 30213639
- DOI: 10.1016/j.ymgme.2018.08.014
Development and clinical consequences of white matter lesions in Fabry disease: a systematic review
Abstract
Background: Fabry disease (FD) is a rare lysosomal storage disorder that might result in, amongst other complications, early stroke and white matter lesions (WMLs). More insight in WMLs in FD could clarify the role of WMLs in the disease presentation and prognosis in FD. In this systematic review we assessed the prevalence, severity, location and course of WMLs in FD. We also systematically reviewed the evidence on the relation between WMLs, disease characteristics and clinical parameters.
Methods: We searched Pubmed, EMBASE and CINAHL (inception to Feb 2018) and identified articles reporting on FD and WMLs assessed with MRI. Prevalence and severity were assessed for all patients combined and divided by sex.
Results: Out of 904 studies a total of 46 studies were included in the analyses. WMLs were present in 46% of patients with FD (581 out of 1276 patients, corrected mean age: 38.8 years, range 11.8-79.3) and increased with age. A total of 16.4% of patients (31 out of 189 patients, corrected mean age: 41.1 years, range 35.8-43.3 years) showed substantial confluent WMLs. Men and women showed comparable prevalence and severity of WMLs. However, men were significantly younger at time of WML assessment. Patients with classical FD had a higher chance on WMLs compared to non-classical patients. Progression of WMLs was seen in 24.6% of patients (49 out of 199 patients) during 38.1 months follow-up. Progression was seen in both men and women, with and without enzyme replacement therapy, but at an earlier age in men. Stroke seemed to be related to WMLs, but cerebrovascular risk factors, cardiac and renal (dys)function did not. Pathology in the brain in FD seemed to extend beyond the WMLs into the normal appearing white matter.
Conclusions: A significant group of FD patients has substantial WMLs and male patients develop WMLs earlier compared to female patients. WMLs could be used in clinical trials to evaluate possible treatment effects on the brain. Future studies should focus on longitudinal follow-up using modern imaging techniques, focusing on the clinical consequences of WMLs. In addition, ischemic and non-ischemic pathways resulting in WML development should be studied.
Keywords: Cerebral Small Vessel Disease; Fabry Disease; Leukoaraiosis; Lysosomal Storage Diseases; MRI; Systematic review; White matter lesions.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease.Cerebrovasc Dis. 2014;38(6):448-56. doi: 10.1159/000369293. Epub 2014 Dec 11. Cerebrovasc Dis. 2014. PMID: 25502511 Clinical Trial.
-
Determinants of cerebral radiological progression in Fabry disease.J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):756-763. doi: 10.1136/jnnp-2019-322268. Epub 2020 Apr 21. J Neurol Neurosurg Psychiatry. 2020. PMID: 32317398
-
Brain MRI findings in children and adolescents with Fabry disease.J Neurol Sci. 2018 Dec 15;395:131-134. doi: 10.1016/j.jns.2018.10.009. Epub 2018 Oct 5. J Neurol Sci. 2018. PMID: 30316069
-
Neurological complications of Anderson-Fabry disease.Curr Pharm Des. 2013;19(33):6014-30. doi: 10.2174/13816128113199990387. Curr Pharm Des. 2013. PMID: 23448452 Review.
-
[Pathophysiological aspects of brain structural disturbances in patients with Fabry disease: literature review].Fortschr Neurol Psychiatr. 2006 Dec;74(12):687-95. doi: 10.1055/s-2006-932190. Fortschr Neurol Psychiatr. 2006. PMID: 17167727 Review. German.
Cited by
-
Fabry disease in females: organ involvement and clinical outcomes compared with the general population (103/150 characters).Orphanet J Rare Dis. 2025 Aug 13;20(1):433. doi: 10.1186/s13023-025-03922-x. Orphanet J Rare Dis. 2025. PMID: 40804726 Free PMC article. Review.
-
Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype- phenotype correlations.Appl Clin Genet. 2019 Mar 5;12:35-50. doi: 10.2147/TACG.S146022. eCollection 2019. Appl Clin Genet. 2019. PMID: 30881085 Free PMC article. Review.
-
Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the Literature.J Clin Med. 2019 May 8;8(5):627. doi: 10.3390/jcm8050627. J Clin Med. 2019. PMID: 31071994 Free PMC article. Review.
-
A systematic literature review to evaluate the cardiac and cerebrovascular outcomes of patients with Fabry disease treated with agalsidase Beta.Front Cardiovasc Med. 2025 Jan 21;11:1415547. doi: 10.3389/fcvm.2024.1415547. eCollection 2024. Front Cardiovasc Med. 2025. PMID: 39906339 Free PMC article.
-
Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study.Brain Sci. 2025 Feb 7;15(2):166. doi: 10.3390/brainsci15020166. Brain Sci. 2025. PMID: 40002499 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical